Lifecore Biomedical, Inc. Revenue 2010–2025
Lifecore Biomedical, Inc. annual/quarterly revenue history and growth rate from 2010 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Lifecore Biomedical, Inc. revenue for the quarter ending March 31, 2026 was 23.2 M, a 83.26% decrease year-over-year.
- Lifecore Biomedical, Inc. revenue for the twelve months ending March 31, 2026 was 122.0 M, a 6.03% increase year-over-year.
- Lifecore Biomedical, Inc. annual revenue for 2025 was 128.9 M, a 0.47% increase from 2024.
- Lifecore Biomedical, Inc. annual revenue for 2024 was 128.3 M, a 24.20% increase from 2023.
- Lifecore Biomedical, Inc. annual revenue for 2023 was 103.3 M, a 7.19% decrease from 2022.
- Lifecore Biomedical, Inc. annual revenue for 2022 was 111.3 M.
Lifecore Biomedical, Inc. (LFCR) — Frequently Asked Questions
Lifecore Biomedical, Inc. (LFCR) is a publicly traded US company. It has a market capitalization of $197M. In fiscal 2025 it reported revenue of $129M and net income of -$39M. Explore LFCR's stock price, financial statements, earnings history, margins and key ratios below.
What is Lifecore Biomedical, Inc.'s market cap?
Lifecore Biomedical, Inc. (LFCR) has a market capitalization of $197M.
What is the LFCR stock price?
LFCR trades at $5.66 (-0.62% on the day).
How much revenue does Lifecore Biomedical, Inc. make?
Lifecore Biomedical, Inc. reported revenue of $129M in fiscal 2025.
Is LFCR profitable?
In fiscal 2025, Lifecore Biomedical, Inc. reported net income of -$39M.